These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A novel role of complement factor C1q in augmenting the presentation of antigen captured in immune complexes to CD8+ T lymphocytes. van Montfoort N; de Jong JM; Schuurhuis DH; van der Voort EI; Camps MG; Huizinga TW; van Kooten C; Daha MR; Verbeek JS; Ossendorp F; Toes RE J Immunol; 2007 Jun; 178(12):7581-6. PubMed ID: 17548593 [TBL] [Abstract][Full Text] [Related]
4. Targeting glycan modified OVA to murine DC-SIGN transgenic dendritic cells enhances MHC class I and II presentation. Singh SK; Stephani J; Schaefer M; Kalay H; García-Vallejo JJ; den Haan J; Saeland E; Sparwasser T; van Kooyk Y Mol Immunol; 2009 Dec; 47(2-3):164-74. PubMed ID: 19818504 [TBL] [Abstract][Full Text] [Related]
5. Dendritic cells, but not macrophages or B cells, activate major histocompatibility complex class II-restricted CD4+ T cells upon immune-complex uptake in vivo. de Jong JM; Schuurhuis DH; Ioan-Facsinay A; Welling MM; Camps MG; van der Voort EI; Huizinga TW; Ossendorp F; Verbeek JS; Toes RE Immunology; 2006 Dec; 119(4):499-506. PubMed ID: 16995881 [TBL] [Abstract][Full Text] [Related]
6. Dendritic cells process synthetic long peptides better than whole protein, improving antigen presentation and T-cell activation. Rosalia RA; Quakkelaar ED; Redeker A; Khan S; Camps M; Drijfhout JW; Silva AL; Jiskoot W; van Hall T; van Veelen PA; Janssen G; Franken K; Cruz LJ; Tromp A; Oostendorp J; van der Burg SH; Ossendorp F; Melief CJ Eur J Immunol; 2013 Oct; 43(10):2554-65. PubMed ID: 23836147 [TBL] [Abstract][Full Text] [Related]
7. Immune complex-loaded dendritic cells are superior to soluble immune complexes as antitumor vaccine. Schuurhuis DH; van Montfoort N; Ioan-Facsinay A; Jiawan R; Camps M; Nouta J; Melief CJ; Verbeek JS; Ossendorp F J Immunol; 2006 Apr; 176(8):4573-80. PubMed ID: 16585547 [TBL] [Abstract][Full Text] [Related]
8. Retrovirally transduced bone marrow-derived dendritic cells require CD4+ T cell help to elicit protective and therapeutic antitumor immunity. De Veerman M; Heirman C; Van Meirvenne S; Devos S; Corthals J; Moser M; Thielemans K J Immunol; 1999 Jan; 162(1):144-51. PubMed ID: 9886380 [TBL] [Abstract][Full Text] [Related]
9. Route of antigen uptake differentially impacts presentation by dendritic cells and activated monocytes. Kamphorst AO; Guermonprez P; Dudziak D; Nussenzweig MC J Immunol; 2010 Sep; 185(6):3426-35. PubMed ID: 20729332 [TBL] [Abstract][Full Text] [Related]
10. Signaling through FcRγ-associated receptors on dendritic cells drives IL-33-dependent TH2-type responses. Tjota MY; Hrusch CL; Blaine KM; Williams JW; Barrett NA; Sperling AI J Allergy Clin Immunol; 2014 Sep; 134(3):706-713.e8. PubMed ID: 25088053 [TBL] [Abstract][Full Text] [Related]
11. Fc gamma receptor IIB on dendritic cells enforces peripheral tolerance by inhibiting effector T cell responses. Desai DD; Harbers SO; Flores M; Colonna L; Downie MP; Bergtold A; Jung S; Clynes R J Immunol; 2007 May; 178(10):6217-26. PubMed ID: 17475849 [TBL] [Abstract][Full Text] [Related]
12. Tumor-specific CD4+ T cells are activated by "cross-dressed" dendritic cells presenting peptide-MHC class II complexes acquired from cell-based cancer vaccines. Dolan BP; Gibbs KD; Ostrand-Rosenberg S J Immunol; 2006 Feb; 176(3):1447-55. PubMed ID: 16424172 [TBL] [Abstract][Full Text] [Related]
13. Fcgamma receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization. Regnault A; Lankar D; Lacabanne V; Rodriguez A; Théry C; Rescigno M; Saito T; Verbeek S; Bonnerot C; Ricciardi-Castagnoli P; Amigorena S J Exp Med; 1999 Jan; 189(2):371-80. PubMed ID: 9892619 [TBL] [Abstract][Full Text] [Related]
14. Ligand binding but undetected functional response of FcR after their capture by T cells via trogocytosis. Hudrisier D; Clemenceau B; Balor S; Daubeuf S; Magdeleine E; Daëron M; Bruhns P; Vié H J Immunol; 2009 Nov; 183(10):6102-13. PubMed ID: 19841164 [TBL] [Abstract][Full Text] [Related]
15. Stroma-dependent development of two dendritic-like cell types with distinct antigen presenting capability. Periasamy P; O'Neill HC Exp Hematol; 2013 Mar; 41(3):281-92. PubMed ID: 23178375 [TBL] [Abstract][Full Text] [Related]
16. Thymic but not splenic CD8⁺ DCs can efficiently cross-prime T cells in the absence of licensing factors. Dresch C; Ackermann M; Vogt B; de Andrade Pereira B; Shortman K; Fraefel C Eur J Immunol; 2011 Sep; 41(9):2544-55. PubMed ID: 21748731 [TBL] [Abstract][Full Text] [Related]
17. Murine Fc receptors for IgG are redundant in facilitating presentation of immune complex derived antigen to CD8+ T cells in vivo. de Jong JM; Schuurhuis DH; Ioan-Facsinay A; van der Voort EI; Huizinga TW; Ossendorp F; Toes RE; Verbeek JS Mol Immunol; 2006 May; 43(13):2045-50. PubMed ID: 16513171 [TBL] [Abstract][Full Text] [Related]
18. Fc alpha receptor cross-linking causes translocation of phosphatidylinositol-dependent protein kinase 1 and protein kinase B alpha to MHC class II peptide-loading-like compartments. Lang ML; Shen L; Gao H; Cusack WF; Lang GA; Wade WF J Immunol; 2001 May; 166(9):5585-93. PubMed ID: 11313398 [TBL] [Abstract][Full Text] [Related]
19. Regulated expression of FcgammaR in human dendritic cells controls cross-presentation of antigen-antibody complexes. Liu Y; Gao X; Masuda E; Redecha PB; Blank MC; Pricop L J Immunol; 2006 Dec; 177(12):8440-7. PubMed ID: 17142741 [TBL] [Abstract][Full Text] [Related]
20. Targeting of Escherichia coli F4 fimbriae to Fcgamma receptors enhances the maturation of porcine dendritic cells. Devriendt B; Verdonck F; Summerfield A; Goddeeris BM; Cox E Vet Immunol Immunopathol; 2010 Jun; 135(3-4):188-98. PubMed ID: 20022123 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]